Sangamo Therapeutics, Inc. (SGMO)
0.4319
+0.01
(+2.83%)
USD |
NASDAQ |
Jan 02, 15:36
Sangamo Therapeutics Total Assets (Quarterly): 88.64M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arcturus Therapeutics Holdings, Inc. | 282.34M |
| AIM ImmunoTech, Inc. | 5.494M |
| Perspective Therapeutics, Inc. | 294.82M |
| Protalix Biotherapeutics, Inc. | 82.26M |
| Armata Pharmaceuticals, Inc. | 89.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 82.40M |
| Shareholders Equity (Quarterly) | 6.243M |
| Debt to Equity Ratio | 4.072 |
| Current Ratio | 0.8793 |
| Net Debt Paydown Yield | 0.34% |